- Home
- A-Z Publications
- Current Cardiology Reviews
- Previous Issues
- Volume 12, Issue 1, 2016
Current Cardiology Reviews - Volume 12, Issue 1, 2016
Volume 12, Issue 1, 2016
-
-
Multimodality Imaging in Cardiac Sarcoidosis: Is There a Winner?
Authors: Irving E. Perez, Mario J. Garcia and Cynthia C. TaubSarcoidosis is a multisystem granulomatous disease of unknown cause that can affect the heart. Cardiac sarcoidosis may be present in as many as 25% of patients with systemic sarcoidosis, and it is frequently underdiagnosed. The early and accurate diagnosis of myocardial involvement is challenging. Advanced imaging techniques play important roles in the diagnosis and management of patients with cardiac sarcoidosis.
-
-
-
Reducing radiation in chronic total occlusion percutaneous coronary interventions
Authors: Antonis N. Pavlidis, Daniel A. Jones, Alex Sirker, Anthony Mathur and Elliot J. SmithThe field of percutaneous intervention for chronic total occlusion (CTO) has enjoyed significant innovations in the recent years. Novel techniques and technologies have revolutionized the field and have resulted in considerably higher success rates even in patients with high anatomical complexity. Successful CTO recanalization is associated with significant clinical benefits, such as the improvement of angina and quality Read More
-
-
-
Adenosine A3 Receptor: A promising therapeutic target in cardiovascular disease
Authors: Shamama Nishat, Luqman A Khan, Zafar M Ansari and Seemi F BasirCardiovascular complications are one of the major factors for early mortality in the present worldwide scenario and have become a major challenge in both developing and developed nations. It has thus become of immense importance to look for different therapeutic possibilities and treatments for the growing burden of cardiovascular diseases. Recent advancements in research have opened various means for better Read More
-
-
-
The Impact of Opioids on Cardiac Electrophysiology
Authors: Erich F. Wedam and Mark C. HaigneySynthetic opioid agents have been used in modern medicine for over a century and for opioid addiction treatment for over a half-century. Liberal use of opioids in the United States has been attended by an extraordinary increase in opioid-related mortality, with over 16,000 deaths in 2012. As there have been advances in opioid agents for pain and addiction, so have there been advances in our understanding of the cardiac effe Read More
-
-
-
GDF 15 - A Novel Biomarker in the Offing for Heart Failure
Authors: Melvin George, Amrita Jena, Varsha Srivatsan, Rajaram Muthukumar and VE DhandapaniBackground: Several diagnostic and prognostic biomarkers are being explored in heart failure. GDF-15 belongs to the transforming growth factor β (TGF-β) cytokine family that is highly up regulated in inflammatory conditions. We undertook this systematic review to summarize the current evidence on the utility of GDF-15 as a biomarker in heart failure. Design and Methods: Multiple electronic databases for studies that repo Read More
-
-
-
Arterial Thickness and Immunometabolism: The Mediating role of Chronic Exercise
Authors: B. M.M. Antunes, S. U. Cayres, F. S. Lira and R. A. FernandesMetabolic alterations and cardiovascular diseases, such as atherosclerosis, are associated with lifestyle modifications, particularly the increase of physical inactivity and poor eating habits, which contribute to one of the main causes of death in modern times. Cardiovascular diseases are positively correlated with several illnesses, such as obesity, hypertension and dyslipidemia, and these disorders are known to contribute Read More
-
-
-
Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice
More LessHCM is the most common inherited heart condition occurring in 1:500 individuals in the general population. Left ventricular outflow obstruction at rest or after provocation occurs in 2/3 of HCM patients and is a frequent cause of limiting symptoms. Pharmacologic therapy is the first-line treatment for obstruction, and should be aggressively pursued before application of invasive therapy. Beta-blockade is given first, and u Read More
-
-
-
Bioresorbable Scaffolds for Atheroregression: Understanding of Transient Scaffolding
More LessThis review focuses on the clinical and biological features of the bioresorbable scaffolds in interventional cardiology highlighting scientific achievements and challenges of the transient scaffolding with Absorb BVS. Special attention is granted to the vascular biology pathways which, involved in the resorption of scaffold, artery remodeling and mechanisms of Glagovian atheroregression setting the stage for subsequen Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/ccr
Journal
10
5
false
en
